Home/Filings/4/0000039911-25-000027
4//SEC Filing

O'Connell Katrina 4

Accession 0000039911-25-000027

CIK 0000039911other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:04 PM ET

Size

22.1 KB

Accession

0000039911-25-000027

Insider Transaction Report

Form 4
Period: 2025-03-14
O'Connell Katrina
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-14$13.93/sh+34,257$477,20034,257 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-03-1412,036135,940 total
    Exercise: $0.00Common Stock (12,036 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-03-144,803131,137 total
    Exercise: $0.00Common Stock (4,803 underlying)
  • Sale

    Common Stock

    2025-03-14$20.34/sh45,772$931,2270 total
  • Sale

    Common Stock

    2025-03-14$20.36/sh34,257$697,5100 total
  • Exercise/Conversion

    Common Stock

    2025-03-14+12,03612,036 total
  • Exercise/Conversion

    Common Stock

    2025-03-15+4,80310,728 total
  • Tax Payment

    Common Stock

    2025-03-15$20.13/sh2,438$49,0778,290 total
  • Tax Payment

    Common Stock

    2025-03-14$20.76/sh6,111$126,8645,925 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2025-03-1434,25734,258 total
    Exercise: $13.93Exp: 2032-03-14Common Stock (34,257 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    670.294
Footnotes (9)
  • [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.03 to $20.96, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F3]The stock option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2024.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.96, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F5]The reporting person and members of her immediate family are among the beneficiaries of this family trust. The reporting person disclaims beneficial ownership of the Gap Inc. common stock held by the trust except to the extent of her pecuniary interest therein.
  • [F6]On March 14, 2022, the reporting person was granted an option to purchase a total of 137,029 shares, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F7]Each restricted stock unit represents a contingent right to receive one share of Gap Inc. Common Stock.
  • [F8]On March 14, 2022, the reporting person was granted 48,143 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F9]On March 15, 2021, the reporting person was granted 19,211 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Issuer

GAP INC

CIK 0000039911

Entity typeother

Related Parties

1
  • filerCIK 0001806953

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:04 PM ET
Size
22.1 KB